16-80612646-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_152342.4(CDYL2):c.1198C>A(p.Gln400Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,458,156 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
CDYL2
NM_152342.4 missense
NM_152342.4 missense
Scores
2
4
12
Clinical Significance
Conservation
PhyloP100: 8.05
Genes affected
CDYL2 (HGNC:23030): (chromodomain Y like 2) Predicted to enable transcription corepressor activity. Predicted to be involved in negative regulation of transcription, DNA-templated. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDYL2 | NM_152342.4 | c.1198C>A | p.Gln400Lys | missense_variant | 5/7 | ENST00000570137.7 | NP_689555.2 | |
CDYL2 | XM_011522866.2 | c.1300C>A | p.Gln434Lys | missense_variant | 5/7 | XP_011521168.1 | ||
CDYL2 | XM_011522867.3 | c.1189C>A | p.Gln397Lys | missense_variant | 5/7 | XP_011521169.1 | ||
CDYL2 | XM_024450151.2 | c.1021C>A | p.Gln341Lys | missense_variant | 5/7 | XP_024305919.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1458156Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 725280
GnomAD4 exome
AF:
AC:
2
AN:
1458156
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
725280
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2024 | The c.1198C>A (p.Q400K) alteration is located in exon 5 (coding exon 5) of the CDYL2 gene. This alteration results from a C to A substitution at nucleotide position 1198, causing the glutamine (Q) at amino acid position 400 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D;.;.;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;N;N
Sift
Benign
.;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
B;.;.;.
Vest4
MutPred
Gain of methylation at Q400 (P = 0.0067);.;.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at